| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Department of Diagnostic and Interventional Radiology, University Hospital
Essen, Hufelandstr. 55, 45122 Essen, Germany.
2 Department of Nuclear Medicine, University Hospital Essen, 45122 Essen,
Germany.
Abstract
OBJECTIVE. Our objective was to show that oral and IV contrast materials improve CT image quality in dual-modality positron emission tomography (PET) and CT, resulting in an increase in diagnostic capacity. We also present a standardized scanning protocol for whole-body PET—CT with oral and IV contrast materials.
SUBJECTS AND METHODS. To evaluate the use of whole-body PET—CT in clinical practice, we examined 30 patients according to the protocol. The CT images were evaluated quantitatively by signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) analyses and qualitatively by two radiologists in consensus. PET quality was assessed quantitatively by measurements of standard uptake values that were compared with standard uptake values in 10 PET—CT examinations without contrast agents.
RESULTS. The application of oral and IV contrast materials led to a highly sufficient delineation of vascular and intestinal structures in 26 of 30 patients. Quantitative analysis revealed a mean vascular SNR of 15.8 ± 7.71 for the 30 patients who received contrast materials compared with 4.79 ± 1.45 for the 10 control group patients (p < 0.001). Similarly, the mean intestinal SNR of 17.06 ± 7.96 far exceeded that seen in the control group of 3.83 ± 1.16 (p < 0.001). Analyses led to a vessel-to-muscle CNR of 10.78 ± 5.89 (control group, -1.21 ± 0.89; p < 0.001) and an intestine-to-muscle CNR of 12.04 ± 6.07 (control group, -2.17 ± 1.22; p = 0.001) in the 30 patients. An evaluation of PET quality in patients who received contrast materials showed a mean standard uptake value of 2.09 ± 1.16 compared with 2.04 ± 0.83 in the control group (p = 0.702).
CONCLUSION. Our whole-body PET—CT protocol provided good vascular and intestinal enhancement without compromising PET quality, leading to a potential improvement in the diagnostic capacity of the combined PET—CT examination.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  W. De Wever, S. Stroobants, J. Coolen, and J. A. Verschakelen Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration Eur. Respir. J., January 1, 2009; 33(1): 201 - 212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H Kuehl, H Eggebrecht, T Boes, G Antoch, S Rosenbaum, S Ladd, A Bockisch, J Barkhausen, and R Erbel Detection of inflammation in patients with acute aortic syndrome: comparison of FDG-PET/CT imaging and serological markers of inflammation Heart, November 1, 2008; 94(11): 1472 - 1477. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Brauck, M. O. Zenge, F. M. Vogt, H. H. Quick, F. Stock, T. Trarbach, M. E. Ladd, and J. Barkhausen Feasibility of Whole-Body MR with T2- and T1-weighted Real-time Steady-State Free Precession Sequences during Continuous Table Movement to Depict Metastases Radiology, March 1, 2008; 246(3): 910 - 916. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Gollub, R. Hong, D. M. Sarasohn, and T. Akhurst Limitations of CT During PET/CT J. Nucl. Med., October 1, 2007; 48(10): 1583 - 1591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Rodriguez-Vigil, N. Gomez-Leon, I. Pinilla, D. Hernandez-Maraver, J. Coya, L. Martin-Curto, and R. Madero PET/CT in Lymphoma: Prospective Study of Enhanced Full-Dose PET/CT Versus Unenhanced Low-Dose PET/CT J. Nucl. Med., October 1, 2006; 47(10): 1643 - 1648. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Brechtel and T. Beyer Reply: Adequate Evaluation of Image Registration in Hybrid PET/CT. J. Nucl. Med., September 1, 2006; 47(9): 1557 - 1558. [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Blake, A. Singh, B. N. Setty, J. Slattery, M. Kalra, M. M. Maher, D. V. Sahani, A. J. Fischman, and P. R. Mueller Pearls and Pitfalls in Interpretation of Abdominal and Pelvic PET-CT RadioGraphics, September 1, 2006; 26(5): 1335 - 1353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Delbeke, R. E. Coleman, M. J. Guiberteau, M. L. Brown, H. D. Royal, B. A. Siegel, D. W. Townsend, L. L. Berland, J. A. Parker, G. Zubal, et al. Procedure Guideline for SPECT/CT Imaging 1.0 J. Nucl. Med., July 1, 2006; 47(7): 1227 - 1234. [Full Text] [PDF]
|
|
|
|
|
|
D. Delbeke, R. E. Coleman, M. J. Guiberteau, M. L. Brown, H. D. Royal, B. A. Siegel, D. W. Townsend, L. L. Berland, J. A. Parker, K. Hubner, et al. Procedure Guideline for Tumor Imaging with 18F-FDG PET/CT 1.0 J. Nucl. Med., May 1, 2006; 47(5): 885 - 895. [Full Text] [PDF]
|
|
|
|
 |
|
 O. Mawlawi, J. J. Erasmus, R. F. Munden, T. Pan, A. E. Knight, H. A. Macapinlac, D. A. Podoloff, and M. Chasen Quantifying the Effect of IV Contrast Media on Integrated PET/CT: Clinical Evaluation Am. J. Roentgenol., February 1, 2006; 186(2): 308 - 319. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tatsumi, C. Cohade, Y. Nakamoto, E. K. Fishman, and R. L. Wahl Direct Comparison of FDG PET and CT Findings in Patients with Lymphoma: Initial Experience Radiology, December 1, 2005; 237(3): 1038 - 1045. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-Y. Yau, W.-S. Chan, Y.-M. Tam, P. Vernon, S. Wong, M. Coel, and S. K.-F. Chu Application of Intravenous Contrast in PET/CT: Does It Really Introduce Significant Attenuation Correction Error? J. Nucl. Med., February 1, 2005; 46(2): 283 - 291. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Gutzeit, G. Antoch, H. Kuhl, T. Egelhof, M. Fischer, E. Hauth, S. Goehde, A. Bockisch, J. Debatin, and L. Freudenberg Unknown Primary Tumors: Detection with Dual-Modality PET/CT--Initial Experience Radiology, January 1, 2005; 234(1): 227 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Romer, M. Chung, A. Chan, D. W. Townsend, F. Torok, B. McCook, M. P. Federle, and N. Avril Single-Detector Helical CT in PET-CT: Assessment of Image Quality Am. J. Roentgenol., June 1, 2004; 182(6): 1571 - 1577. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Beyer, G. Antoch, S. Muller, T. Egelhof, L. S. Freudenberg, J. Debatin, and A. Bockisch Acquisition Protocol Considerations for Combined PET/CT Imaging J. Nucl. Med., January 1, 2004; 45(90010): 25S - 35. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Wahl Why Nearly All PET of Abdominal and Pelvic Cancers Will Be Performed as PET/CT J. Nucl. Med., January 1, 2004; 45(90010): 82S - 95. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. K. Pannu, R. E. Bristow, C. Cohade, E. K. Fishman, and R. L. Wahl PET-CT in Recurrent Ovarian Cancer: Initial Observations RadioGraphics, January 1, 2004; 24(1): 209 - 223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Antoch, F. M. Vogt, L. S. Freudenberg, F. Nazaradeh, S. C. Goehde, J. Barkhausen, G. Dahmen, A. Bockisch, J. F. Debatin, and S. G. Ruehm Whole-Body Dual-Modality PET/CT and Whole-Body MRI for Tumor Staging in Oncology JAMA, December 24, 2003; 290(24): 3199 - 3206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Nehmeh, Y. E. Erdi, H. Kalaigian, K. S. Kolbert, T. Pan, H. Yeung, O. Squire, A. Sinha, S. M. Larson, and J. L. Humm Correction for Oral Contrast Artifacts in CT Attenuation-Corrected PET Images Obtained by Combined PET/CT J. Nucl. Med., December 1, 2003; 44(12): 1940 - 1944. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Antoch, J. Stattaus, A. T. Nemat, S. Marnitz, T. Beyer, H. Kuehl, A. Bockisch, J. F. Debatin, and L. S. Freudenberg Non-Small Cell Lung Cancer: Dual-Modality PET/CT in Preoperative Staging Radiology, November 1, 2003; 229(2): 526 - 533. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
